Program

DAY1Wednesday, November 13

Please click each presentation title to see the abstract.

Opening Remarks & Lectures
Chair: Nagahiro Minato, Kyoto University
9:00-9:05
Opening remarks
Tasuku Honjo (CCII, Kyoto University)
9:05-9:50
Plenary
Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy
Suzanne Louise Topalian (Johns Hopkins University School of Medicine)
9:50-10:05
On the biochemical dialog between immune cells mediating anti-cancer responses
Sidonia Fagarasan (CCII, Kyoto University)
Session 1: T Cell Therapy
Chair: Hiroyoshi Nishikawa, CCII, Kyoto University
10:05-10:45
CAR T cells for cancer and beyond
Carl June (University of Pennsylvania)
10:45-11:25
T cells naturally designed and selected to sense and eliminate cancer cells
Hilde Cheroutre (La Jolla Institute for Immunology)
11:25-11:40
Break
Session 2: Myeloid Cells, PD-1 and Beyond
Chair: Osamu Takeuchi, Kyoto University
11:40-12:20
Induction and therapeutic exploitation of PD-1 tolerogenic function
Vassiliki Boussiotis (Harvard Medical School)
12:20-13:00
Liquid biopsy: from discovery to clinical implementation
Klaus Pantel (University Medical Center Hamburg-Eppendorf)
13:00-14:00
Break
Session 3: Immunometabolism
Chair: Sidonia Fagarasan, CCII, Kyoto University
14:00-14:40
High dimensional dissection and therapeutic engineering of the tumor immune microenvironment
Drew M. Pardoll (Johns Hopkins University School of Medicine)
14:40-15:00
Short talk
Novel immune evasion mechanisms involving mitochondria in the tumor microenvironment
Yosuke Togashi (Okayama University)
15:00-15:20
Short talk
Volatile oxidized lipids as noninvasive biomarkers for monitoring ferroptosis in cells, animal models, and human breath
Yuki Sugiura (CCII, Kyoto University)
15:20-15:35
Break
Session 4: Cancer Antigens and Tolerance
Chair: Hideki Ueno, Kyoto University
15:35-16:15
Molecular base of tumor neoantigens: intracellular expression of non-self MHC class I- and II-restricted chimeric epitopes reverses resistance to cancer immunotherapy
Kenji Chamoto (CCII, Kyoto University)
16:15-16:55
Single-cell Treg profiling: new cancer therapies and insights into tumor-Treg biology
Eliane Piaggio (Curie Institute)
16:55-17:35
Cancer-mediated immunosuppression in the tumor microenvironment identified by immuno-genomic analyses
Hiroyoshi Nishikawa (CCII, Kyoto University)

NEW

17:40-18:20
Meet the Editors Session
Students and early career researchers are encouraged to participate in “Meet the Editors” session and discuss with the editors of the first class papers.
Editors: Alexandra Flemming, Chief editor, Nature Reviews Immunology
Bernd Pulverer, Chief editor, EMBO Reports